[The effect of decreased thromboxane synthesis on proliferative glomerulonephritis].
The authors investigated in 19 patients with chronic proliferative glomerulonephritis the effect of 100 mg acetylsalicylic acid (ACA) administered for 12 months and the effect of 50 mg ACA administered for the same period. They evaluated the effect of the two doses on the urinary excretion of PGI and TXA2 metabolites as well as the effect on proteinuria and glomerular filtraction (GF). The authors provided evidence that small and very small amounts of ACA did not affect the excretion of the PGI metabolite, while they reduced significantly the excretion of the TXA2 metabolite and of proteinuria, and significantly increased GF.
Knotková
V
V
II. interní klinika 1. lékarské fakulty Univerzity Karlovy, Praha.
Petrů
I
I
Nĕmecek
K
K
Jáchymová
M
M
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000328:Adult; D001241:Aspirin / Q000494:pharmacology; D002908:Chronic Disease; D003404:Creatinine / Q000652:urine; D005260:Female; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000503:physiopathology* / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D011507:Proteinuria; D013931:Thromboxanes / Q000652:urine*
D013931:Thromboxanes; D015121:6-Ketoprostaglandin F1 alpha; D003404:Creatinine; D001241:Aspirin
Vliv snízené syntézy tromboxanu na průbĕh proliferativní glomerulonefritidy.